RxDoctor Payments DataLook up a doctor →

Samuel Asirvatham, MD

Clinical Cardiac Electrophysiology · Rochester, MNNPI 1932189750

Payments from drug & device makers

$1,049,128in general payments, 2019–2025

Across 546 payments — averaging $1921.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$348K
  • Biosense Webster, Inc.$279K
  • Biotronik Inc.$129K
  • Boston Scientific$123K
  • Abbott$77K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$57K
  • plus $37K from 2 others
$436,418in research payments, 2019–2025

Across 7 payments — averaging $62,345 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biosig Technologies, Inc.$436K
  • Biotronik Inc.$750

What the payments were for

  • Consulting fees$534,69751%
  • Speaking & faculty fees$296,75628%
  • Grants$3,9540%
  • Travel & lodging$205,06420%
  • Food & beverage$8,6161%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,049,128 in reported general payments places this provider in the 95th percentile of 72 clinical cardiac electrophysiology providers in Minnesota.

See all clinical cardiac electrophysiology providers in Minnesota

Medicare billing

Part B allowed, 2024
$113,277
Medicare patients
1,076
Services billed
2,052

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban13$20,907
Amiodarone Hcl14$457

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →